Exelixis, Inc. (LON:0IJO)
London · Delayed Price · Currency is GBP · Price in USD 42.83
+0.24 (0.56%)
At close: Feb 12, 2026
Exelixis Market Cap
Exelixis has a market cap or net worth of 8.17 billion as of February 12, 2026. Its market cap has increased by 9.18% in one year.
Market Cap
8.17B
Enterprise Value
7.10B
Revenue
1.72B
Ranking
n/a
PE Ratio
14.06
Stock Price
42.83
Market Cap Chart
Since April 11, 2000, Exelixis's market cap has increased from 409.19M to 8.17B, an increase of 1,897.48%. That is a compound annual growth rate of 12.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 8.17B | -6.77% |
| Dec 31, 2025 | 8.77B | 15.41% |
| Dec 31, 2024 | 7.60B | 29.70% |
| Dec 29, 2023 | 5.86B | 36.40% |
| Dec 30, 2022 | 4.29B | 0.53% |
| Dec 31, 2021 | 4.27B | -6.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| Convatec Group | 4.29B |
| Hikma Pharmaceuticals | 3.44B |
| Genus | 2.06B |
| HUTCHMED (China) | 1.88B |